The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Emphysema Drug Market Research Report 2024

Global Emphysema Drug Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1389262

No of Pages : 81

Synopsis
The global Emphysema Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Emphysema Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Emphysema Drug.
Report Scope
The Emphysema Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Emphysema Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Emphysema Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Angion Biomedica Corp.
ProMetic Life Sciences Inc.
rEVO Biologics, Inc.
SATT North SAS
TGV-Laboratories
Segment by Type
BB-3
EDO-66
MG-53
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Emphysema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Emphysema Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Emphysema Drug Market Overview
1.1 Product Overview and Scope of Emphysema Drug
1.2 Emphysema Drug Segment by Type
1.2.1 Global Emphysema Drug Market Value Comparison by Type (2024-2030)
1.2.2 BB-3
1.2.3 EDO-66
1.2.4 MG-53
1.2.5 Others
1.3 Emphysema Drug Segment by Application
1.3.1 Global Emphysema Drug Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Emphysema Drug Market Size Estimates and Forecasts
1.4.1 Global Emphysema Drug Revenue 2019-2030
1.4.2 Global Emphysema Drug Sales 2019-2030
1.4.3 Global Emphysema Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Emphysema Drug Market Competition by Manufacturers
2.1 Global Emphysema Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Emphysema Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Emphysema Drug Average Price by Manufacturers (2019-2024)
2.4 Global Emphysema Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Emphysema Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Emphysema Drug, Product Type & Application
2.7 Emphysema Drug Market Competitive Situation and Trends
2.7.1 Emphysema Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Emphysema Drug Players Market Share by Revenue
2.7.3 Global Emphysema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Emphysema Drug Retrospective Market Scenario by Region
3.1 Global Emphysema Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Emphysema Drug Global Emphysema Drug Sales by Region: 2019-2030
3.2.1 Global Emphysema Drug Sales by Region: 2019-2024
3.2.2 Global Emphysema Drug Sales by Region: 2025-2030
3.3 Global Emphysema Drug Global Emphysema Drug Revenue by Region: 2019-2030
3.3.1 Global Emphysema Drug Revenue by Region: 2019-2024
3.3.2 Global Emphysema Drug Revenue by Region: 2025-2030
3.4 North America Emphysema Drug Market Facts & Figures by Country
3.4.1 North America Emphysema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Emphysema Drug Sales by Country (2019-2030)
3.4.3 North America Emphysema Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Emphysema Drug Market Facts & Figures by Country
3.5.1 Europe Emphysema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Emphysema Drug Sales by Country (2019-2030)
3.5.3 Europe Emphysema Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Emphysema Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Emphysema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Emphysema Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Emphysema Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Emphysema Drug Market Facts & Figures by Country
3.7.1 Latin America Emphysema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Emphysema Drug Sales by Country (2019-2030)
3.7.3 Latin America Emphysema Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Emphysema Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Emphysema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Emphysema Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Emphysema Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Emphysema Drug Sales by Type (2019-2030)
4.1.1 Global Emphysema Drug Sales by Type (2019-2024)
4.1.2 Global Emphysema Drug Sales by Type (2025-2030)
4.1.3 Global Emphysema Drug Sales Market Share by Type (2019-2030)
4.2 Global Emphysema Drug Revenue by Type (2019-2030)
4.2.1 Global Emphysema Drug Revenue by Type (2019-2024)
4.2.2 Global Emphysema Drug Revenue by Type (2025-2030)
4.2.3 Global Emphysema Drug Revenue Market Share by Type (2019-2030)
4.3 Global Emphysema Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Emphysema Drug Sales by Application (2019-2030)
5.1.1 Global Emphysema Drug Sales by Application (2019-2024)
5.1.2 Global Emphysema Drug Sales by Application (2025-2030)
5.1.3 Global Emphysema Drug Sales Market Share by Application (2019-2030)
5.2 Global Emphysema Drug Revenue by Application (2019-2030)
5.2.1 Global Emphysema Drug Revenue by Application (2019-2024)
5.2.2 Global Emphysema Drug Revenue by Application (2025-2030)
5.2.3 Global Emphysema Drug Revenue Market Share by Application (2019-2030)
5.3 Global Emphysema Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Angion Biomedica Corp.
6.1.1 Angion Biomedica Corp. Corporation Information
6.1.2 Angion Biomedica Corp. Description and Business Overview
6.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Angion Biomedica Corp. Emphysema Drug Product Portfolio
6.1.5 Angion Biomedica Corp. Recent Developments/Updates
6.2 ProMetic Life Sciences Inc.
6.2.1 ProMetic Life Sciences Inc. Corporation Information
6.2.2 ProMetic Life Sciences Inc. Description and Business Overview
6.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ProMetic Life Sciences Inc. Emphysema Drug Product Portfolio
6.2.5 ProMetic Life Sciences Inc. Recent Developments/Updates
6.3 rEVO Biologics, Inc.
6.3.1 rEVO Biologics, Inc. Corporation Information
6.3.2 rEVO Biologics, Inc. Description and Business Overview
6.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 rEVO Biologics, Inc. Emphysema Drug Product Portfolio
6.3.5 rEVO Biologics, Inc. Recent Developments/Updates
6.4 SATT North SAS
6.4.1 SATT North SAS Corporation Information
6.4.2 SATT North SAS Description and Business Overview
6.4.3 SATT North SAS Emphysema Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SATT North SAS Emphysema Drug Product Portfolio
6.4.5 SATT North SAS Recent Developments/Updates
6.5 TGV-Laboratories
6.5.1 TGV-Laboratories Corporation Information
6.5.2 TGV-Laboratories Description and Business Overview
6.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TGV-Laboratories Emphysema Drug Product Portfolio
6.5.5 TGV-Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Emphysema Drug Industry Chain Analysis
7.2 Emphysema Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Emphysema Drug Production Mode & Process
7.4 Emphysema Drug Sales and Marketing
7.4.1 Emphysema Drug Sales Channels
7.4.2 Emphysema Drug Distributors
7.5 Emphysema Drug Customers
8 Emphysema Drug Market Dynamics
8.1 Emphysema Drug Industry Trends
8.2 Emphysema Drug Market Drivers
8.3 Emphysema Drug Market Challenges
8.4 Emphysema Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’